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Tyrosine Phosphorylation of IkB-a Activates
NF-kB without Proteolytic Degradation of IkB-a
Ve´ronique Imbert,* Rudolf A. Rupec,† Antonia Livolsi,* Phosphorylation is one of the most frequent and im-
portant posttranslational modification of proteins. It wasHeike L. Pahl,† E. Britta-Mareen Traenckner,†
also shown to be an important regulator of TF activityChristoph Mueller-Dieckmann,† Dariush Farahifar,*
(Karin, 1994). In the case of the NF-kB/Rel family ofBernard Rossi,* Patrick Auberger,*
TFs (reviewed in Baeuerle and Henkel, 1994; Liou andPatrick A. Baeuerle,†‡ and Jean-Franc¸ois Peyron*
Baltimore, 1993), serine phosphorylation triggers a pro-*Inserm Unite´ 364
teolytic degradation of inhibitory subunits, called IkBFaculte´ de Me´decine Pasteur
proteins (Brockman et al., 1995; Brown et al., 1995;F-06107, Nice Cedex 02
Traenckner et al., 1995). The activation of TFs by proteinFrance
kinases can directly couple events at cell surface recep-†Institute of Biochemistry
tors to nuclear gene expression. STAT factors requireAlbert-Ludwigs-University
only one kinase in their signal transduction pathwayHermann Herder-Str. 7
whereas activation of the nuclear SRF/ets complex in-D-79104, Freiburg
volves activation of an entire kinase cascade.Germany
NF-kB/Rel TFs are composed of five distinct DNA-
binding subunits, called p50, p52, p65/RelA, c-Rel, and
Rel-B (Liou and Baltimore, 1993). The different family
Summary members can associate in various homo- or heterodim-
ers through a highly conserved N-terminal sequence,
The transcription factor NF-kB regulates genes partic- called the NRD (NF-kB/rel/Dorsal) (Grimm and Baeuerle,
ipating in immune and inflammatory responses. In T 1993) or Rel homology domain. NF-kB complexes con-
lymphocytes, NF-kB is sequestered in the cytosol by taining the p65 subunit seem to have a pivotal role in
the inhibitor IkB-a and released after serine phosphor- the generation of an immune response. NF-kB, which
ylation of IkB-a that regulates its ubiquitin-dependent is activated by antigens, viruses, bacteria, prooxidants,
degradation. We report an alternative mechanism of and inflammatory lymphokines, participates in the tran-
NF-kB activation. Stimulation of Jurkat T cells with scriptional initiation of diverse genes whose products
the protein tyrosine phosphatase inhibitor and T cell are important in immune and inflammatory responses.
activator pervanadate led to NF-kB activation through Examples are the genes encoding interleukins 21, 22,
tyrosine phosphorylation but not degradation of IkB-a. 26, and 28, IL-2 receptor a chain, various adhesion
Pervanadate-induced IkB-a phosphorylation and NF- molecules, major histocompatibility class I molecules,
kB activation required expression of the T cell tyrosine and immunoglobulin k light chain (Baeuerle and Henkel,
kinase p56lck.Reoxygenation of hypoxic cells appeared 1994).
as a physiological effector of IkB-a tyrosine phosphor- Inactive NF-kB is present in the cytosol associated
ylation. Tyrosine phosphorylation of IkB-a represents with an inhibitory molecule of the IkB family (Baeuerle
a proteolysis-independent mechanism of NF-kB acti- and Baltimore, 1988). All six known members of the IkB
vation that directly couples NF-kB to cellular tyrosine family (IkB-a, IkB-b, IkB-g, Bcl-3, p100, p105, reviewed
kinase. in Beg and Baldwin, 1993) contain an ankyrin (ANK)
repeat domain that is composed of 5–7 closely adjacent
repeats required for both association with NF-kB andIntroduction
inhibitory activity (Beg and Baldwin, 1993). Interaction
of IkB-a with an NF-kB dimer prevents the nuclear up-Signal transduction pathways are complex networks of
take of the DNA-binding subunits through the maskingbiochemical reactions that ultimately culminate in spe-
of nuclear localization signals (Beg et al., 1992; Zabelcific patterns of nuclear gene expression mediated by
et al., 1993). Uncomplexed IkB-a can enter the nucleustranscription factors (TFs). Preexisting TFs that are in-
and may dissociate DNA-bound NF-kB–DNA com-volved in immediate-early cellular responses can be
plexes. Phosphorylation of IkB-a by various kinases hasposttranslationally activated by a variety of mecha-
been shown to dissociate NF-kB–IkB-a complexes innisms. A frequent strategy is the induction of DNA bind-
vitro (Ghosh and Baltimore, 1990). The situation is rathering activity that may involve the dimerization of subunits.
different in vivo where phosphorylation of IkB-a on ser-For instance, binding of steroid hormones or tyrosine
ine residues 32 and 36 does not lead to dissociation ofphosphorylation with subsequent SH2 domain interac-
the NF-kB–IkB-a complex but targets IkB-a for rapidtion can promote DNA binding via dimerization of sub-
degradation by the proteasome (Brockman et al., 1995;units. A large number of TFs translocate from the cyto-
Brown et al., 1995; Traenckner et al., 1995).plasm to the nucleus as part of their activation process.
Tyrosine phosphorylation of proteins by protein tyro-Other TFs are already bound to DNA but require some
sine kinases (PTKs) is a primary and important step incovalent modification to unleash their transactivating
the initiation of various mitogenic signaling cascadespotential.
(Ullrich and Schlessinger, 1990; Cantley et al., 1991).
Engagement of receptor-associated PTKs stimulates
the ras/raf-1/map kinase pathway (Johnson and Vaillan-‡Present address: Tularik Inc., 270 East Grand Avenue, South San
Francisco, California 94080. court, 1994), which leads to activation of the c-fos and
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c-jun proto-oncogenes via phosphorylation of pre-
existing DNA-bound factors in their transactivation do-
main (Karin, 1994; Hill and Treisman, 1995). Moreover,
PTKs have recently been shown to directly activate a
new family of TFs, the STAT factors (Darnell et al., 1994).
A direct role of tyrosine phosphorylation in NF-kB
activation is not well documented. Two reports have
shown that c-rel and IkB proteins become tyrosine phos-
phorylated upon neutrophil activation and hypoxia, re-
spectively, but the significance of the modifications re-
mained unknown (Druker et al., 1994; Koong et al., 1994).
One report showed that v-src overexpression in T cells
caused NF-kB activation (Eicher et al., 1994) while an-
other study showed that v-abl overexpression blocked
NF-kB activity in pre-B cells (Klug et al., 1994).
In a previous study, we have shown that a protein
tyrosine phosphatase (PTP) inhibitor, pervanadate,
stimulates protein tyrosine phosphorylation and down-
stream events of the T-cell activation process including
induction of NF-kB DNA-binding activity (Imbert et al.,
1994). We demonstrate here that there is a direct con-
nection between PTK stimulation and NF-kB activation
through tyrosine phosphorylation of IkB-a. In contrast
to other activators of NF-kB, tyrosine phosphorylation
of IkB-a does not lead to degradation of the protein.
Tyrosine phosphorylation of IkB-a induces dissociation
from NF-kB and precedes the appearance of a DNA
binding activity on kB sites in the nucleus. Lck-deficient
mutants of Jurkat had a defect in both tyrosine phos-
phorylation of IkB-a and NF-kB activation. Reoxygena-
tion of hypoxic cells was shown to induce tyrosine phos-
phorylation of IkB-a. Tyrosine phosphorylation of IkB-a
thus represents a new mechanism of NF-kB activation
that has the potential to directly couple NF-kB to surface
receptor–associated tyrosine kinases.
Results
Pervanadate Activates the DNA Binding
Activity of NF-kB
We have previously reported that pervanadate is a po- Figure 1. Pervanadate-Induced NF-kB-DNA Binding Activity
tent activator of Jurkat leukemic T cells (Imbert et al., (A) Dose response effect of pervanadate (lanes 1–9). Jurkat cells
1994) through its ability to increase tyrosine phosphory- were stimulated for 1 hr with the indicated doses of pervanadate,
PMA (10 ng/ml), and calcium ionophore A23187 (2 mM). Nuclearlation of cellular proteins after inhibition of protein tyro-
extracts were incubated with a 32P-labeled NF-kB probe corre-sine phosphatases (PTPs). As determined by electro-
sponding to the kB site in the IL-2 gene promoter and analyzed byphoretic mobility shift assay (EMSA), a 1 hr stimulation
EMSA. NF-kB-DNA specific complex and nonspecific complex are
with pervanadate induced a dose-dependent appear- indicated. Characterization of pervanadate effect (lanes 10–14).
ance of an NF-kB–DNA binding activity in the nuclei of Cells were stimulated with 200 mM pervanadate, 200 mM H2O2 or
stimulated Jurkat cells (Figure 1A, compare lanes 4–6 200 mM vanadate. Control pV represents a mixture containing only
catalase and H2O2.to lane 1). The effect of 250 mM pervanadate (Figure 1A,
(B) Analysis of pervanadate-induced NF-kB complexes. Extracts oflane 4) was as strong as that of phorbol 12-myristate 13-
pervanadate-stimulated cells were incubated with control IgG (laneacetate (PMA) (Figure 1A, lane 3). The two compounds
1), anti-p50 (lane 2), p65 (lane 3), or HA (lane 4) antibodies prior to
showed an additive effect (Figure 1A, lanes 7–9) similar EMSA analysis. The specificity of the complex was analyzed by
to that observed with the combination of PMA and a incubation with an excess of unlabeled kB (lane 5) or AP-1 (lane 6)
calcium ionophore (lane 2). When cells were stimulated oligonucleotides.
(C) Effect of EGTA and H7 on pervanadate- or PMA-induced NF-with 200 mM H2O2 alone, (Figure 1A, lane 12), 200 mM
kB. Jurkat cells were incubated in a calcium-freemedium containingvanadate alone (lane 14), or with H2O2 in the presence
1 mM EGTA or preincubated for 20 min with H7 (100 mM) prior toof catalase (control pV, lane 13) no induction of NF-kB-
stimulation with pervanadate (200 mM) or PMA (10 ng/ml) for 1h.
DNA binding activity could be detected, demonstrating (D) Effect of tyrosine kinase inhibitors. Cells were preincubated with
that the observed activation was due to vanadate perox- genistein (100 mM) or staurosporine (50 nM) 20 min before stimula-
ide (pervanadate). tion with pervanadate or PMA for 1 hr.
Incubation of pervanadate-stimulated cell extracts
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with anti-p50 (Figure 1B, lane 2) or anti-p65 antibodies used for immunoprecipitation with control IgG (Figure
2B, lanes 1 and 2) or with the IkB-a-specific antibody(lane 3) resulted in the abrogation of NF-kB/DNA com-
plexes, whereas control IgG (lane 1) or an irrelevant (lanes 3 and 4) followed by Western blot analysis with
the aP-Tyr mAb. A 10 min stimulation of Jurkat cellsinfluenza hemagglutinin-specific antibody had no effect
(lane 4). The specificity of the pervanadate-induced pro- with pervanadate induced tyrosine phosphorylation of
IkB-a (Figure 2B, lane 4). The immunoaffinity-purifiedtein–DNA complex was further confirmed by the demon-
stration that an excess (100-fold) of unlabeled kB oligo- tyrosine phosphorylated form of IkB-a migrated at the
same position as the 39 kDa protein detected by West-nucleotide (Figure 1B, lane 5) but not of an AP-1
oligonucleotide (lane 6) prevented its binding to the 32P- ern blotting with IkB-a antibodies in pervanadate-
treated cells. No tyrosine phosphorylated IkB-a couldlabeled kB probe. These results show that pervanadate
activated a bona fide p50–p65 NF-kB dimer in Jurkat be detected in unstimulated cells (Figure 2B, lane 3).
Maximal tyrosine phosphorylation of IkB-a occurred be-cells.
tween 15 and 30 min of pervanadate stimulation (Figure
2C). These results show that pervanadate induces anPervanadate-Induced NF-kB Activation Is
apparently stochiometric de novo phosphorylation ofIndependent of Protein Kinase C- and
human IkB-a on tyrosine that results in an apparentCalcium-Regulated Events but Is
molecular size increase of 2 kDa.Blocked by PTK Inhibitors
Preincubation of cells with the PKC inhibitor H7 did not
detectably affect the activation of NF-kB by pervanadate The Appearance of the Pervanadate-Induced 39 kDa
Form of IkB-a Is Blocked by PTK Inhibitors(Figure 1C, compare lane 4 to lane 2) while it strongly
suppressed NF-kB stimulation by PMA (lane 6). More- Preincubation of Jurkat cells with 50 nM staurosporine
for 20 min completely prevented the induction of the 39over, we did not detect any stimulation of PKC by per-
vanadate (data not shown). While addition of EGTA to kDa variant by pervanadate (Figure 2D, compare lanes
4 and 7 to lane 2). Genistein (100 mM) was less effectivethe medium blocked the calcium influx stimulated by
pervanadate (Imbert et al., 1994), it had no effect on and only partially prevented tyrosine phosphorylation of
IkB-a by 200 mM pervanadate (lane 3). When pervana-pervanadate-induced NF-kB activation (Figure1C, com-
pare lanes 2 and 3). The effect of pervanadate thus date was used at a suboptimal (50 mM) concentration,
genistein completely blocked the appearance of the 39appeared to be independent of PKC- and calcium-
dependent signals. kDa IkB-a variant (lane 6). By contrast, the PKC inhibitor
H7 did not prevent IkB-a tyrosine phosphorylation inPreincubation of Jurkat cells with 100 mM of the PTK
inhibitor genistein strongly reduced activation of NF-kB response to 200 mM pervanadate (compare lanes 10
and 9).by pervanadate (Figure 1D, compare lanes 2 and 3).
Genistein also affected the induction of NF-kB by PMA
(compare lanes 4 and 5). Staurosporine in the nanomolar Protein Tyrosine Phosphatase Treatment
range has been described as a powerful PTK inhibitor, Converts the 39 kDa Variant of IkB-a
while higher concentrations will inhibit PKC in addition into the 37 kDa Variant
(Secrist et al., 1990). As shown in Figure 1D, 50 nM To verify that the mobility shift of IkB-a in response to
staurosporine completely blocked NF-kB induction by pervanadate was entirely due to tyrosine phosphoryla-
pervanadate (compare lanes 7 and 8) but had no effect tion, we treated the cell lysates with recombinant PTP1C
on PMA induction (lane 10). These pharmacological data fused to glutathione-S-transferase (GST) and coupled
suggest that activation of one orseveral PTKs isa critical to agarose. To ensure that exogenously added pervana-
event in the activation of NF-kB by pervanadate. date would not block GST-PTP1C, we removed the ex-
cess pervanadate by extensive washing of the cellsafter
stimulation, expecting that the intracellular pervanadatePervanadate Induces Phosphorylation
of IkB-a on Tyrosine is depleted through reaction. Moreover, vanadate was
omitted from the lysis buffer. The 39 kDa variant of IkB-aWe did not detect tyrosine phosphorylation of p50 or
p65. However, analysis of aP-Tyr immunoprecipitates in pervanadate-stimulated Jurkat cells (Figure 2E, lane
2) was still observed in vanadate-free lysis buffer (laneby Western blotting with a polyclonal serum directed
against human IkB-a suggested that pervanadatestimu- 6). Incubation in the presence of GST-PTP1C did not
affect the migration of the 37 kDa IkB-a from normallated tyrosine phosphorylation of IkB-a within 10 min
(Figure 2A, compare lanes 2 and 1). cells (lane 5) but completelyconverted the39 kDavariant
from pervanadate-stimulated cells (lane 6) into a formAs shown on an anti-IkB-a Western blot of whole
cell lysates, pervanadate stimulation did not alter the precisely comigrating with the37 kDavariant of nonstim-
ulated cells (lane 7). The dephosphorylation activity ofamount of IkB-a protein (Figure 2A, compare lanes 3
and 4; see also Figure 3) but induced a change in the PTP1C on IkB-a was blocked by addition of vanadate
to the lysis buffer (lane 3). To demonstrate the activitymobility of IkB-a in SDS gels with an apparent molecular
size of 37 kDa in unstimulated cells (Figure 2A, lane 3) of PTP1C, cellular proteins from total lysates were ana-
lyzed by Western blotting with aP-Tyr mAb. Incubationto 39 kDa in pervanadate-treated cells (lane 4). Almost
all IkB-a detected by Western blotting was affected by with PTP1C markedly decreased pervanadate-induced
tyrosine phosphorylation (compare lane 10 to lane 9),the mobility reduction. Maximal pervanadate stimulation
occurred at 200 mM (data not shown). Cell lysates from except when vanadate was present during lysis
(lane 11).pervanadate-treated or untreated Jurkat cells were then
Cell
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Figure 2. Pervanadate Induces Tyrosine
Phosphorylation of IkB-a
(A) After cell stimulation, cell lysates were im-
munoprecipitated with anti-phosphotyrosine
mAb (lanes 1 and 2) or left untreated (lanes
3 and 4) followed by a Western blot with anti-
IkB-a antiserum.
(B) Lysates were incubated with control Ig
(lanes 1 and 2) or anti-IkB-a mAb (lanes 3 and
4) before analysis of tyrosine phosphorylation
by Western blotting with anti-phosphotyro-
sine mAb.
(C) Time course of IkB-a phosphorylation.
Phosphorylation was analyzed by immuno-
precipitation with anti-IkB-a mAb and West-
ern blotting with anti-phosphotyrosine mAb.
(D) Effect of kinase inhibitors on pervanadate-
induced IkB-a mobility shift. Cells wereprein-
cubated for 20 min with H7 (100 mM), gen-
istein (100 mM) or staurosporine (50 nM)
before stimulation with pervanadate (200 mM:
lanes 2–4, 9, and 10 or 50 mM: lanes 5–7).
Phosphorylation was analyzed by anti-IkB-a
Western blotting.
(E) Dephosphorylation of IkB-a by PTP1C.
Cell lysates were made in the presence (lanes
1–3 and 11) or absence (lanes 4–10) of vana-
date and left untreated (lanes 1, 2, 4, 6, 8, and
9) or treated (lanes 3, 5, 7, 10, and 11) with
PTP1C-agarose for 1 hr at 308C. A Western
blotting analysis with anti-IkB-a antiserum
(lanes 1–7) or anti-phosphotyrosine mAb
(lanes 8–11) was performed.
Pervanadate-Induced Tyrosine Phosphorylation phosphorylated IkB-a. This half life is very similar to the
one measured for unmodified IkB-a from unstimulatedDoes Not Trigger Degradation of IkB-a
At various times after stimulation, whole cell lysates cells (data not shown) demonstrating that tyrosine phos-
phorylation did not affect the half-life of IkB-a.were analyzed by Western blotting with anti-IkB-a se-
rum. After 30 min of pervanadate stimulation, all detect- When cells were stimulated with a combination of a
calcium ionophore and PMA, no shift in the migrationable IkB-a protein was in the tyrosine phosphorylated
39 kDa form (Figure 3A, upper panel). No variation in of IkB-a was detected (Figure 3A, lower panel), but a
rapid degradation of the molecule occurred that wasthe amount of 39 kDa IkB-a was detected for up to 150
min. Newly synthetized IkB-a, which started to appear enhanced by pretreatment with cycloheximide. In this
case, the half life of IkB-a decreased to z25 min (Figureafter z60 min, was immediately converted into the tyro-
sine phosphorylated form. Next, Jurkat cells were prein- 3B). Thus, incontrast to serine phosphorylation, tyrosine
phosphorylation does not target IkB-a for rapid degra-cubated with cycloheximide to prevent new IkB-a syn-
thesis. Under these conditions, some degradation of 39 dation. However, when cells were stimulated with per-
vanadate 15 min before or at the same time as thekDa IkB-a could be observed. After quantitation of IkB-a
levels by scanning the autoradiograms (Figure 3B), a combination of A23187 1 PMA, a sharp decrease in the
amount of tyrosine-phosphorylated IkB-a was observedhalf-life of 120–140 min was determined for tyrosine
Tyrosine Phosphorylation of IkB-a
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Figure 3. Pervanadate Does Not Induce Deg-
radation of IkB-a
(A) Cells were left untreated or pretreatedwith
cycloheximide (10 mg/ml for 30 min) before
activation with pervanadate (200 mM) or a
combination of A23187 (2 mM) and PMA (10
ng/ml). At the indicated times cell aliquots
were harvested and analyzed by IkB-a West-
ern blotting.
(B) Half life of IkB-a after activation. The levels
of the different forms of IkB-a, after stimula-
tion with pervanadate or A23187 and PMA in
the presence of cycloheximide, were evalu-
ated by scanning the autoradiogram shown
on (A).
(C) Tyrosine phosphorylated IkB-a is sensi-
tive to A23187 1 PMA–induced degradation.
For all conditions, cells were pretreated for
30 min with cycloheximide (10 mg/ml); A23187
(2 mM) and PMA (10 ng/ml) were then added
after or at the same time as pervanadate
(200 mM).
and no IkB-a protein was detected 2 hr after stimulation in protein-DNA complexes, immunodepletion experi-
ments were performed. Total cell extracts were incu-(Figure 3C). These results show that tyrosine phosphory-
bated with anti-p65 or anti-IkB-a antibodies preab-lation of IkB-adoes not protect the molecule from degra-
sorbed to protein A-sepharose, and supernatants weredation and support that pervanadate did not influence
analyzed for the presence of NF-kB-DNA binding activitythe proteolytic pathway responsible for IkB-a degra-
by EMSA. As shown in Figure 4B, incubation with anti-dation.
p65 antibodies depleted theNF-kB–DNA binding activity
that was induced by either pervanadate (lane 8) or the
combination of calcium ionophore and PMA (lane 9). ByInduction of Tyrosine Phosphorylation by
contrast, control IgG (lanes 1–3) or anti-IkB-a antibodyPervanadate Correlates with Dissociation
(lanes 4–6) did not diminish the amount of NF-kB-DNAof IkB-a/NF-kB Complexes
complex. These results demonstrate that tyrosine phos-IkB-a immunoprecipitates from pervanadate-treated
phorylation dissociates IkB-a from NF-kB.cells were tested for the presence of p65 NF-kB by
Western blotting. In unstimulated cells, p65 was found
associated with IkB-a (Figure 4A, lane 1). The amount No Tyrosine Phosphorylation of IkB-a
of coprecipitating p65 decreased with time (lanes 2–4). in Lck-Deficient Jurkat Variants
No p65 could be detected in association with tyrosine- Triggering the T cell receptor on JCaM1 cells that lack
phosphorylated IkB-a after 1 hr (lane 4). A 15 min stim- Lck activity because of a splicing defect failed to stimu-
ulation with a combination of PMA/ionophore also late tyrosine phosphorylation of cellular proteins, cal-
reduced the association (lane 5). To rule out that tyro- cium influx, and late activation events such as CD69
expression (Strauss and Weiss, 1992). Transfection ofsine-phosphorylated IkB-a was still attached to NF-kB
Cell
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Figure 4. IkB-a Dissociates from NF-kB upon Tyrosine Phosphory-
lation
(A) Coprecipitation IkB-a/p65. Total cell extracts from unstimulated
Jurkat cells (lane 1) or cells treated with pervanadate (200 mM) for
various time periods (lanes 2–4) or with A23187 (2 mM) 1 PMA (10
ng/ml) for 15 min (lane 5) were incubated with anti-IkB-a antibodies
preadsorbed to protein A-sepharose. Immune complexes were then
analyzed by Western blotting with anti-p65 NF-kB antibodies.
(B) Immunodepletion. Total cell extracts from unstimulated (lanes
1, 4, and 7), pervanadate (200 mM) (lanes 2, 5, and 8) or A23187 (2
mM) 1 PMA (10 ng/ml) (lanes 3, 6, and 9) treated Jurkat cells were
incubated with control (lanes 1–3), anti-IkB-a (lanes 4–6), or anti-
p65 (lanes 7–9) antibodies preadsorbed to protein A-sepharose.
Figure 5. Analysis of IkB-a Phosphorylation and NF-kB Induction
After removal of immune complexes by centrifugation, supernatants
in Lck-Deficient Variants of Jurkat
were analyzed by EMSA.
(A) Pervanadate failed to induce a slowly migrating form of IkB-a in
JCaM1 cells. Cell extracts were analyzed by anti-IkB-a Western
blotting.
lck cDNA in JCaM1 restored full TcR-CD3 signaling (B) Global tyrosine phosphorylation of cellular proteins. Cellular ex-
(Strauss and Weiss, 1992). In a time course experiment tracts from Jurkat (lanes 1–4) or JCaM1 cells (lanes 5–8) were ana-
lyzed by anti-phosphotyrosine Western blotting.(Figure 5A), no tyrosine phosphorylation-dependent mo-
(C) Pervanadate failed to activate NF-kB in JCaM1 cells. NF-kB-bility shift of IkB-a was observed in JCaM1 cells (lanes
DNA binding activity was analyzed as described in legend to Fig-5–8), in contrast to normal Jurkat cells (lanes 1–4). Tyro-
ure 1.
sine phosphorylation of some but not all cellular proteins
induced by pervanadate was affected in JCaM1 cells
(Figure 5B, lanes 5–8) when compared to Jurkat cells tyrosine 289 (D289), 248 (D248), or 181 (D181) were re-
placed by STOP codons (Figure 6A). The different con-(lanes 1–4). Pervanadate also failed to activate NF-kB-
DNA binding activity in JCaM1, even after 60 min of structs were then transiently transfected in COS cells.
Tyrosine phosphorylation of wild-type IkB-a was onlystimulation (Figure 5C, lanes 6–9; compare to parental
Jurkat, lanes 1–4). However, a PMA/ionophore stimula- induced by pervanadate when an expression vector for
the tyrosine kinase lck was cotransfected (Figure 6B,tion could activate NF-kB in JCaM1 cells (lane 10) as in
normal cells (lane 5), demonstrating that JCaM1 cells lanes 3 and 4 compared to lanes 1 and 2). Tyrosine
phosphorylation of the D181 mutant could also only bedid not have a general defect in NF-kB activation. The
T cell–specific tyrosine kinase p56lck thus appears es- observed in the presence of lck (Figure 6B, lanes 7 and
8 compared to lanes 5 and 6). Identical results weresential for pervanadate-induced NF-kB activation by
IkB-a tyrosine phosphorylation. obtained with D289 and D248 mutants (data not shown).
This demonstrates the importance of lck in the control
of IkB-a tyrosine phosphorylation in response to pervan-The Tyrosine Phosphorylation Site in IkB-a
To identify the tyrosine residue responsible for the mo- adate and points at tyrosine 42 as the potential phos-
phorylation site. Tyrosine 42 was then mutated to phe-bility shift of IkB-a in response to pervanadate, C-termi-
nal deletions were constructed in which the codons for nylalanine both in full-length IkB-a and in the truncated
Tyrosine Phosphorylation of IkB-a
793
Figure 6. Localization of Tyrosine Phosphor-
ylation Sites on IkB-a
(A) Physical map of IkB-a and schematic rep-
resentation of deletion mutants.
(B) Cos cells were transfected with wild-type
IkB-a (lanes 1–4) or different mutants: D181
mutant (lanes 5–10), D181Y42F (lanes 11 and
12), Y42F single mutant (lanes 13, 14), S32/
36 double mutant (lanes 15, 16), and without
(lanes 1, 2 5, 6) or with lck (lanes 3, 4, 7–16).
After 48 hr cells were stimulated with pervan-
adate (250 mM for 20 min, even lanes). Cell
extractswere analyzed by anti-IkB-a Western
blotting. The open arrowheads point to the
nonphosphorylated forms of IkB-a whereas
the closed ones point to the tyrosine phos-
phorylated species.
mutant D181. Mutation of tyrosine 42 entirely blocked sine kinase required the presence of its ligand, insulin
(Figure 7C, compare lane 8 to lane 6). Insulin was re-the appearance of the tyrosine phosphorylation–depen-
cently reported to activate NF-kB. Together, the resultsdent migration shift on both full-length IkB-a (Figure 6B,
suggest that NF-kB activity can be reversibly regulatedlanes 13 and 14) and the truncated protein D181 (lanes
by tyrosine phosphorylation/dephosphorylationof IkB-a.11 and 12). Mutations of serines 32 and 36 to alanines
did not affect the generation of the slower migrating
Reoxygenation Is a Physiological Effectorform of IkB-a in response to pervanadate (lanes 15 and
of IkB-a Tyrosine Phosphorylation16). Altogether, these results strongly suggest that IkB-a
A recent report by Koong et al. (1994) suggested thatis phosphorylated on tyrosine 42 after pervanadate
hypoxia induces tyrosine phosphorylation of IkB-a. Astreatment of intact cells.
shown in Figure 8A (lane 5) hypoxia did not induce the
appearance of a tyrosine phosphorylated 39 kDa IkB-aCell-Free Phosphorylation/
variant. However, as reported recently (Rupec andDephosphorylation Experiments
Baeuerle, 1995) reoxygenation of hypoxic cell cultures
We tested whether tyrosine phosphorylated IkB-a in cell
potently activated NF-kB (Figure 8B, lane 3). Reoxygen-
extracts from pervanadate-treated cells can reinhibit
ation induced the conversion of IkB-a into a 39 kDa
NF-kB after treatment with the CD45 tyrosine phospha-
variant that was not degraded during a 90 min reoxygen-
tase. Cell extracts from control or pervanadate-stimu- ation period (Figure 8A, lanes 2–4) as seen upon pervan-
lated Jurkat cells were incubated with immunopre- adate treatment. The effect was already maximal after
cipitated CD45 and the NF-kB–DNA binding activity 30 min (Figures 8A, lane 2). Immunoprecipitation with
analyzed by EMSA (Figure 7A). CD45 treatment strongly anti-PTyr mAb verified that reoxygenation induced
decreased the NF-kB activity in extracts from pervana- phosphorylation of IkB-a on tyrosine (data not shown).
date-stimulated cells (lane 4). Blocking CD45 with vana- In support of this notion, the PTK inhibitor staurosporine
date reversed the effect of CD45 (lane 6). In contrast, blocked NF-kB activation in response to reoxygenation
NF-kB activity in extracts from PMA/ionophore-treated of hypoxic Jurkat cell cultures (Figure 8B, lane 2). This
Jurkat cells did not decrease upon CD45 treatment (data identifies reoxygenation as a physiological stimulus of
not shown). In a second set of experiments, we tested IkB-a tyrosine phosphorylation and subsequent NF-kB
whether a purified PTK can relieve the inhibitory effect activation.
of recombinant IkB-a. Activated NF-kB in extracts from
pervanadate-stimulated Jurkat cells (Figures 7B and 7C, Discussion
lanes 2) was inhibited upon addition of rIkB-a (lanes 4).
This did not occur when either Lck tyrosine kinase (Fig- Regulation of NF-kB Activation
ure 7B, lane 5) or insulin receptor tyrosine kinase (Figure by Serine Phosphorylation
7C, lane 8) were added and incubated under phosphory- Phosphorylation is involved in the regulation of the activ-
ity of many TFs. It may regulate subcellular localization,lation conditions. The effect of the Insulin receptor tyro-
Cell
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Figure 8. Reoxygenation Induces Tyrosine Phosphorylation of
IkB-a and PTK-Dependent Activation of NF-kB
Jurkat cells were incubated in hypoxic conditions for 5 min, followed
by re-exposure to atmospheric oxygen.
(A) IkB-a mobility shift. Reoxygenation time course (lanes 2–4). Hyp-
oxic condition (lane 5). The extracts were analyzed by anti-IkB-a
Western blotting.
(B) Preincubation with staurosporine (lane 2) prevented reoxygena-
tion-induced NF-kB-DNA binding activity (lane 3).
Figure 7. In Vitro Phosphorylation/Dephosphorylation Experiments
et al., 1991), presumably by casein kinase II (Barroga etCellular extracts were incubated for 1hr at 308C with phosphatase or
al., 1995), but the role of this modification is unknown.kinases. NF-kB-DNA-binding activity was then visualized by EMSA.
Many if not all activators of NF-kB have been reported(A) Dephosphorylation by CD45. Cellular extracts from untreated
(lanes 1, 3, and 5) or 30 min pervanadate-activated Jurkat cells to induce degradation of IkB-a (Beg and Baldwin, 1993;
(lanes 2, 4, and 6) were mixed with immunoprecipitated CD45 in the Henkel et al., 1993). This degradation is preceded by
absence (lanes 3 and 4) or the presence (lanes 5 and 6) of vanadate activation of an as yet unidentified protein serine kinase
in the reaction mixture .
that phosphorylates IkB-a on serines 32 and 36 within(B) Phosphorylation by Lck.Total extracts from pervanadate-treated
an N-terminal-regulatory domain (see pathway Ion regu-Jurkat cells, containing NF-kB-DNA-binding activity (lane 2) were
latory model in Figure 9) (Brockman et al., 1995; Brownincubated with 1 ng of rIkB-a (lanes 3–5) without (lanes 3 and 4) or
with Lck tyrosine kinase (lane 5). et al., 1995; Traenckner et al., 1995). Phosphorylation
(C) Phosphorylation by insulin receptor tyrosine kinase. Extracts on these sites does not lead to dissociation of IkB-a
from untreated (lanes 1, 3, 5, and 7) or 30 min pervanadate-activated from NF-kB (Finco et al., 1994; Miyamoto et al., 1994;
Jurkat cells (lanes 2, 4, 6, and 8) were incubated alone (lanes 1 and
Palombella et al., 1994; Alkalay et al., 1995; Brown et2) or with rIkB-a (lanes 3–8) in the presence of nonactivated (lanes
al., 1995; DiDonato et al., 1995; Lin et al., 1995; Traenck-5 and 6) or insulin-activated insulin receptor (lanes 7 and 8).
ner et al., 1995) Mutation of serines 32 and 36 to alanine
residues prevents inducible phosphorylation and degra-
dation of IkB-a. Moreover, mutated IkB-a can act as adimerization, binding to DNA, or the transactivation po-
dominant negative mutant to attenuate kB-dependenttential. Phosphorylation is an important regulator of NF-
transactivation (Brown et al., 1995; Traenckner et al.,kB activation at different levels. Both, the p50 and p65
1995).subunits of NF-kB are phosphorylated (Naumann and
Scheidereit, 1994). Although the sites and kinases have
not been identified, phosphorylation appears to play Regulation of NF-kB Activation
by Tyrosine Phosphorylationa role in increasing the affinity of NF-kB for its target
sequences (Naumann and Scheidereit, 1994). cAMP- Inhibition of tyrosine phosphatases by pervanadate in
Jurkat cells leads to a rapid increase in tyrosine phos-dependent phosphorylation events were reported to
down-modulate NF-kB activity in T cells (Serfling et al., phorylation of cellular proteins followed by triggering of
the T cell activation cascade (Secrist et al., 1993; Imbert1989). Most importantly, phosphorylation regulates ac-
tivity of the inhibitor IkB-a, which sequesters NF-kB et al., 1994). One of the events induced is a potent
activation of NF-kB that appears to be entirely mediatedin the cytosol. Several studies reported that IkB-a is
constitutively phosphorylated (Davis et al., 1991; Kerr by de novo phosphorylation of IkB-a on tyrosine. This
Tyrosine Phosphorylation of IkB-a
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Figure 9. Model of NF-kB Activation
Pathway I: activation of NF-kB through deg-
radation of IkB-a. PMA, phorbol ester; TNF,
tumor necrosis factor; OA, okadaic acid; ROI,
reactive oxygen intermediates; PSK, protein
serine kinase; PSP, protein serine phospha-
tase; Ub, ubiquitin. SS, serines 32 and 36.
Pathway II: NF-kB activation through tyrosine
phosphorylation of IkB-a. PTK, protein tyro-
sine kinase; PTP, protein tyrosine phospha-
tase; X, unidentified effector; pV, pervana-
date. Y, tyrosine 42.
is evident from the absence of significant tyrosine phos- it a potential phosphorylation site for tyrosine kinases.
Amino acids at 11 and 13 create a potential bindingphate from the DNA binding subunits of NF-kB and the
stoichiometric modification of IkB-a. The latter is sug- site for the SH2 domain of the p85 subunit of PI3 kinase
(Haskill et al., 1991; Songyang et al., 1993).gested by a stimulus-dependent complete conversion
of IkB-a into the phosphoform (39 kDa) and its complete
reversion into the dephospho form (37 kDa) upon PTP Which Tyrosine Kinase Activates NF-kB
treatment. At present, we cannot completely rule out upon Pervanadate Stimulation?
that the tyrosine phosphorylation of IkB-a was accom- Pervanadate is a powerful inducer of tyrosine phosphor-
panied by some serine or threonine phosphorylation, ylation in many cell types. In Jurkat cells, pervanadate
but these could not have accounted for the change in triggers several signaling pathways through lck, fyn,
IkB-a mobility, suggesting that they were substoichio- zap-70 (Imbert et al., 1996), and Jak-2 (V. I. and J.-F. P.,
metric. The tyrosine phosphorylation of IkB-a was an unpublished data). We could so far not identify which
early event and closely coincided with the activation of PTK catalyzed tyrosine phosphorylation of IkB-a. Inter-
NF-kB. estingly, tyrosine phosphorylation of IkB-a and NF-kB
activation were both impaired in Lck-deficient Jurkat
How May Tyrosine Phosphorylation
variants, suggesting that IkB-acould be phosphorylated
Release IkB-a?
by Lck or by an Lck-activated PTK that remains to be
In contrast to serine phosphorylation, tyrosine phos- identified. Reconstitution experiments in COS cells also
phorylation of IkB-a did not lead to degradation of the demonstrate the requirement for lck for induction of
molecule. The normal turnover of IkB-a of 2 hr was not IkB-a tyrosine phosphorylation.
detectably modified by tyrosine phosphorylation while Expression of a constitutive PTK, v-src, in T-cells has
it was decreased to 25 min by serine phosphorylation. been reported to induce a constitutive activation of NF-
Moreover, inhibition of proteasome proteolytic activity
kB in the nucleus (Eicher et al., 1994). In addition, v-src
did not affect NF-kB induction by pervanadate (data expression could transactivate the HIV LTR in a kB-
not shown). In vitro phosphorylation/dephosphorylation dependent manner, suggesting that increase in tyro-
experiments strongly suggested that tyrosine phosphor- sine phosphorylation could influence NF-kB activation.
ylation directly interfered with the interaction between However, since these cells also displayed constitutive
IkB-a and NF-kB. IkB-a contains eight potential tyrosine NFAT activation, it was not clear whether these events
phosphorylation sites (Haskill et al., 1991) that are highly were directely regulated by tyrosine phosphorylation or
conserved among species (de Martin et al., 1995). Muta-
whether they represented downstream events of a tyro-
tional analysis hinted at phosphorylation of IkB-a on Tyr
sine phosphorylation-induced cascade (Eicher et al.,
42. Tyrosine 42 is located in the N-terminal regulatory 1994).
region in close proximity to serines 32 and 36, which
regulate degradation of IkB-a. Tyrosine-phosphorylated
Reoxygenation Induces Tyrosinepeptides can be specifically recognized by SH2 do-
Phosphorylation of IkB-amains, which are structural motifs found in numerous
NF-kB has been reported to respond to changes in thecytoplasmic signaling proteins (Pawson, 1995). Phos-
cellular redox status and to be activated by prooxidantphorylated tyrosine 42 in IkB-a may bind an SH2 do-
conditions (reviewed in Baeuerle and Henkel, 1994). Onemain-containing protein. It may be this interaction that
study has suggested that IkB-a can undergo tyrosineultimately removes the inhibitor from an equilibrium
phosphorylation during hypoxia (Koong et al., 1994).binding with NF-kB. This attractive possibility is cur-
While we were unable to detect NF-kB activation uponrently under investigation. The presence of acidic resi-
dues from 21 to 23 to tyrosine 42 (DEEYEQM) makes hypoxia we have observed an induction of IkB-a tyrosine
Cell
796
EGTA 0.1 mM, DTT 1 mM, PMSF 0.1%, Aprotinin 0.1%) (Baeuerlephosphorylation after reoxygenation of hypoxic Jurkat
and Baltimore, 1988). Supernatants from a 15,000 g, 15 min centrifu-cells (Rupec and Baeuerle, 1995). The discrepancy with
gation were collected.the results of Koong et al. (1994) could be due to a
For mobility shift assay the NF-kB probe was a synthetic double-
reoxygenation artifact in their experimental conditions. stranded oligonucleotide containing the NF-kB binding site of the
The activation of NF-kB by reoxygenation appears to IL-2 gene promoter (59-GATCCAAGGGACTTTCCATG-39). The end-
labeled probe was incubated with nuclear or totex extract samplesbe a very rapid event, since a maximal induction could
(10 mg) for 20min at 378C. Complexes wereseparated by electropho-be reached within 15 min (data not shown). Our results
resis on a 5% nondenaturating polyacrylamide gel in 0.53 TBE.suggest that reactive oxygen intermediates (ROI) could
For in vitro phosphorylation, partially purified Lck or insulin recep-be inducers of tyrosine phosphorylation of IkB-a. For
tor were used. InsR was prepared from NIH 3T3 fibroblasts stably
instance, H2O2 is a potent inhibitor of tyrosine phospha- transfected with the insulin receptor cDNA. Insulin receptor was
tases leading to the activation of PTKs (Heffetz et al., activated by incubation with 1027 M insulin for 50 min at room tem-
perature. Phosphorylation were performed in HEPES 10 mM (pH1992). In T cells, H2O2 activates lck, fyn, zap-70, and syk
7.4), NaCl 150 mM, ATP 15 mM, MnCl2 8 mM, MgCl2 4 mM for 30(Schieven et al., 1993; Schieven et al., 1994; and our
min at 258C.unpublished observations). It remains to be understood
why most of the stimuli that have been reported to acti-
Mutant Construction and Transfectionvate NF-kB through an ROI-dependent mechanism ap-
The IkB-a cDNA plasmid (Zabel et al., 1993) was used as a templatepear to use the regular pathway of NF-kB activation via
for further polymerase chain reaction amplification. The full length
degradation of IkB-a. The ROI species (H2O2, •O2-, or sequence was amplified using sense primer A (59-CGGAATTCCAGG
•OH) or their site of production may be important regula- CGGCCGAGCGCCCC-39) containing a EcoRI site and reverse
tory parameters. Our observations and hypotheses are primer (59-GGGGTACCTCATAACGTCAGACGCTG-39) containing a
KpnI site and further subcloned in the EcoRI/KpnI sites of pcDSRasummarized in Figure 9 (pathway II).
mammalian expression vector. C-terminal deletions were con-
structed by polymerase chain reaction amplification using senseTyrosine Phosphorylation of IkB-a
primer A and reverse D181 primer in which the tyr181 codon hasand Oncogenesis been replaced by a stop codon (bold) and that included a KpnI
IkB-a has been proposed as a possible tumor suppres- site (59-GGGGTACCTCATTGGTAGCCTTCAGGATG-39). Mutation of
sor since overexpression of IkB-a anti-sense RNA in 3T3 tyrosine 42 has been performed with a Transformer site-directed
mutagenesis kit from Clontech (Palo Alto, CA) using a primer wherecells induced malignant transformation (Beauparlant et
the codon for tyrosine 42 has been replaced by a codon for phenylal-al., 1994). Constitutive tyrosine phosphorylation of IkB-a
anine (59-AAAGACGAGGAGTTCGAGCAGATGGTC-39). The S32/36Amay participate in the transforming activity of oncogenic
mutant has been previously described (Traenckner et al., 1995). LckPTKs by inducing a constitutive activation of the genes cDNA in pEFBOS vector was a kind gift of Dr. A. Carrera.
controlled by NF-kB. COS-7 cells were seeded at 25% confluency on 6-well plates
24 hr before transfection. After washing with phosphate-buffered
Experimental Procedures saline, transfection was carried out in Dulbecco’s modified Eagle’s
medium (DMEM) 10% Nu-serum (CBP, Bedford, MA) supplemented
Antibodies and Reagents with 200 mg DEAE-dextran (Pharmacia), 100 mM chloroquine, and
Antibodies used in this study are: anti-IkB-a rabbit polyclonal, anti- 1.5 mg of each vector for 4.5 hr. Dimethyl sulfoxide 10% was then
p50 rabbit polyclonal, anti-p65 rabbit polyclonal (Santa Cruz Bio- added for 2 min. Cells were then washed twice in phosphate-buf-
technology, Santa Cruz, CA), anti-phosphotyrosine 4G10 (UBI, Lake fered saline and incubated in DMEM 10% fetal calf serum for 48 hr
Placid, NY). A polyclonal affinity-purified antibody to human IkB-a before harvest and further analysis.
was prepared and used as described (Henkel et al., 1993). The
polyclonal anti-p65 serum and the anti-HA antibody were kindly
Reoxygenation Experimentsgiven by J. Imbert and Profs. Klenck and Garten, respectively. Par-
These experiments were performed as described (Rupec andtially purified Lck and recombinant glutathione-S-transferase (GST)
Baeuerle, 1995): DMEM medium with the bicarbonate buffer re-fused PTP1-C were from Upstate Biotechnology, Inc. (Lake Placid,
placed by 25 mM HEPES (pH 7.2) was placed in a chamber andNY). Pervanadate was prepared by mixing vanadate in incubation
equilibrated overnight with nitrogen. The hypoxic medium wasbuffer (30 mM HEPES [pH 7.5], 150 mM NaCl, 4 mM KCl, 0.8 mM
added to the cells that were immediately placed into the chamber,MgSO4, 1.8 mM CaCl2, 10 mM glucose) with 1 mM H2O2 for 15 min which was subsequently flushed with nitrogen at 2 bars for 5 min.at 228C. Catalase (200 mg/ml) was then added to remove residual
No significant increase in the oxygen pressure in the cell cultureH2O2. The concentration of pervanadate generated is denoted by medium was measured with this regimen. For reoxygenation, thethe vanadate concentration added to the mixture.
lid of the chamber was simply removed. Control experiments at
normal oxygen pressure were identically performed but in theCell Culture
opened chamber.Cells of the human leukemic T cell line Jurkat were maintained in
RPMI 1640 medium containing 50 U/ml penicillin, 50 mg/ml strepto-
mycin, 1 mM sodium pyruvate, 2 mM glutamine, and 5% fetal calf Acknowledgments
serum (GIBCO, Cergy Pontoise, France). JCaM1 cells were obtained
from ATCC (Rockville, MD). Correspondence should be addressed to J.-F. P. (email: peyron@
unice.fr). We thank Dr. Jean Imbert and also Isabelle Mothe and Dr.
E. Van Obberghen for the gift of anti-p65 antibody and purifiedImmunoprecipitation—Immunoblotting
Cell stimulation, preparation of lysates, immunoprecipitation, and insulin receptor preparations, respectively. We thank Raymond
Mescatullo for illustration work and Georg Hartl for construction ofWestern blot analysis were performed as previously described (Im-
bert et al., 1994). the hypoxia chamber. R. A. R was supported by a grant from the
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Recherche contre le Cancer (ARC No. 3094 to J.-F. P.).When indicated, NF-kB-DNA binding activity was analyzed in total
cellular extracts made in Totex lysis buffer (HEPES 20 mM [pH 7.9],
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